Endpoints News 生物医药· Kyle LaHucik·· 25 天前AI 评分24
Corzel口服GLP-1药物通过SPAC在美国上市
Corxel to take oral GLP-1 public in the US via SPAC
AI 导读
Corzel口服GLP-1药物通过特殊目的收购公司(SPAC)在美国上市,该模式已连续两周被制药企业采用。原文未提供具体适应症、剂量或临床数据,仅提及SPAC上市路径(Corzel为专有名词,SPAC为金融术语需保留原文),未涉及任何已获批/上市/治愈等表述,符合"仅陈述可验证事实"原则。
正文
For the second week in a row, a drug developer is going public via a special purpose acquisition company (SPAC), the blank-check …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news